Validity and reliability of four value frameworks for cancer drugs.

被引：0
|
作者：
Bentley, Tanya G. K.
Cohen, Joshua T.
Elkin, Elena B.
Huynh, Julie
Mukherjea, Arnab
Neville, Thanh H.
Mei, Matthew Genyeh
Copher, Ronda
Knoth, Russell L.
Popescu, Ioana
Lee, Jackie
Zambrano, Jenelle
Broder, Michael
机构：
[1] Partnership Hlth Analyt Res LLC, Beverly Hills, CA USA
[2] Tufts Med Ctr, Boston, MA 02111 USA
[3] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[4] Harbor Univ Calif Los Angeles Med Ctr, Redondo Beach, CA USA
[5] Calif State Univ, Hlth Sci Program, Hayward, CA USA
[6] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[7] City Hope Comprehens Canc Ctr, Duarte, CA USA
[8] Eisai & Co Ltd, Woodcliff Lake, NJ USA
[9] Eisai & Co Ltd, Orange, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.6603
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6603
引用
收藏
页数：6
相关论文
共 50 条
  • [21] Reliability and validity in measuring the value added of schools
    van de Grift, Wim
    SCHOOL EFFECTIVENESS AND SCHOOL IMPROVEMENT, 2009, 20 (02) : 269 - 285
  • [22] Musings on value frameworks in cancer
    Subramanian, Ram
    Schorr, Kevin
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2016, 5 (05) : 437 - 439
  • [23] Reliability and validity studies of four tests of malingering.
    Gayda, CA
    Pickholtz, JL
    Edwards, D
    Williams, JM
    ARCHIVES OF CLINICAL NEUROPSYCHOLOGY, 1996, 11 (05) : 394 - 394
  • [24] Nuclear morphology determines the response of cancer cells to anticancer drugs.
    Afyani, F. Atrian
    Duffey, C.
    Ochoa, M.
    Ziaie, B.
    Lelievre, S. A.
    MOLECULAR BIOLOGY OF THE CELL, 2016, 27
  • [25] How to Value Orphan Drugs? A Review of European Value Assessment Frameworks
    Blonda, Alessandra
    Denier, Yvonne
    Huys, Isabelle
    Simoens, Steven
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [26] Glycoprotein glycosylation: Targets for new anti-cancer drugs.
    Dennis, JW
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 212 : 38 - CARB
  • [27] International comparison on the factors influencing reimbursement of expensive cancer drugs.
    Lim, Carol Sunghye
    Kwon, Soonil
    Lee, Yun-Gyoo
    Koh, Youngil
    Heo, Dae Seog
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [28] Simple organotin polyethers as potential anti-cancer drugs.
    Siegmann-Louda, D
    Carraher, CE
    Nagy, D
    Snedden, D
    Ross, J
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U505 - U505
  • [29] New antitarget antineoplastic drugs. Clinical indications in the treatment of cancer
    Jose Grau, Juan
    Caballero, Miguel
    Tagliapetra, Andrea
    MEDICINA CLINICA, 2011, 137 (08): : 370 - 376
  • [30] Australian health technology assessment of companion testing for cancer drugs.
    Kim, Hansoo
    Cook, Greg
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12345